A

argenx

Develops antibody-based therapies for autoimmune diseases

Global Digital Technology Lead Development

IT OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • Deep understanding of clinical development processes, including clinical trials, study execution, and regulatory requirements.
  • Strong experience with Development-related platforms, such as clinical systems, data platforms, and analytics environments.
  • Proven ability to define and execute multi-year technology strategies and roadmaps in a complex, regulated environment.
  • Ability to translate complex scientific and operational challenges into actionable technology solutions.
  • Experience engaging senior leadership in global organizations.
  • Ability to operate amid ambiguity and drive clarity, alignment, and decisions.
  • Demonstrated leadership in cross-functional, global teams.
  • Master’s degree in Life Sciences, Engineering, Computer Science, or a related field.
  • At least 10 years of experience in Digital Technology or IT within a biopharmaceutical or life sciences environment.
  • Strong experience supporting Clinical Development, R&D, or related GxP-regulated domains.
  • Proven track record leading large-scale technology portfolios and transformation programs.
  • Experience working with senior stakeholders in Development, R&D, or Clinical Operations within a global organization.
  • Strong people leadership capabilities, with experience building and scaling global teams.
  • Ability to work collaboratively within cross-functional teams and networks.
  • Demonstrated communication skills in a multicultural and multilingual global environment.
  • Experience with project management, proactive planning, priority setting, and securing alignment.

Responsibilities

  • Define the technology vision and multi-year roadmap for Development in alignment with R&D and clinical strategy.
  • Act as the strategic interface between Digital Technology and Development leadership, ensuring alignment on priorities and outcomes.
  • Govern the portfolio of Development technology initiatives from ideation and prioritization through value realization and benefit tracking.
  • Lead delivery of a coherent digital ecosystem supporting clinical trials, data platforms, and Development operations.
  • Serve as a senior advisor on Development technologies, translating scientific and operational needs into scalable solutions.
  • Ensure solutions meet regulatory requirements, including GxP, data integrity, and validation, and adhere to quality standards.
  • Drive innovation and continuous improvement in Development processes through digital capabilities and data leverage.
  • Foster collaboration across Development, Data, Regulatory, Quality, and external partners.
  • Lead complex programs and manage dependencies across a global, matrixed environment.
  • Champion co-creation, accountability, and outcomes-driven delivery within the Digital Technology Development capability.
  • Build, lead, and develop a high-performing global Digital Technology Development team, including talent development, performance management, and succession planning.
  • Shape and embed the Development operating model within the Digital Technology organization, including ways of working, governance, and value tracking.
  • Build and maintain strategic partnerships with Development technology vendors; understand their capabilities, product roadmaps, and innovation agendas to inform technology decisions and maximize business value.
  • Travel at least 20%.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs